Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Nordic Nanovector ASA ( (DE:8NN) ) just unveiled an announcement.
Thor Medical ASA announced that Jorunn Sandnes, a close associate of the company’s board chairperson, Ludvik Sandnes, has been allocated 50,000 shares in the company’s subsequent offering at a subscription price of NOK 2.5 per share. This transaction, subject to mandatory notification requirements, reflects compliance with the EU Market Abuse Regulation and the Norwegian Securities Trading Act. The allocation highlights Thor Medical’s ongoing capital activities and the strategic involvement of key stakeholders, potentially influencing market perceptions and investor confidence.
More about Nordic Nanovector ASA
Thor Medical ASA is an emerging supplier of radionuclides, primarily focusing on alpha particle emitters derived from naturally occurring thorium. The company employs a proprietary production process that does not require irradiation or the use of nuclear reactors, ensuring a reliable, environmentally friendly, and cost-efficient supply of alpha-emitters for the radiopharmaceutical industry. Headquartered in Oslo, Norway, Thor Medical is listed on the Oslo Stock Exchange under the ticker symbol ‘TRMED’.
YTD Price Performance: 3.64%
Average Trading Volume: 5,269
Technical Sentiment Consensus Rating: Sell
Current Market Cap: €72.81M
Find detailed analytics on 8NN stock on TipRanks’ Stock Analysis page.
